Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX)

Clinical trial NCT07528417 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07528417
Sponsor: University of Manitoba
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myeldysplastic Syndrome (MDS)MYELOPROLIFERATIVE DISORDER (P Vera, CMML, ET)Acute Myeloid Leukemia

Start date: 2026-09-01
Primary completion: 2028-04-30
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.